Agile Therapeutics reported $29.3M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Adma Biologics ADMA:US $ 308.03M 31.78M
Agile Therapeutics AGRX:US $ 29.3M 10.03M
Bayer BAYN:GR € 125782M 5541M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Pacira Pharmaceuticals PCRX:US $ 1733.99M 157.49M
Pain Therapeutics PTIE:US $ 244.19M 22.59M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M
Therapeuticsmd TXMD:US 133.38M 36.09M